• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Securities
Disclosure Plus

FINETEK CO., LTD. Signs 19.5 Billion Won Contract to Supply OLED Manufacturing Equipment

FINETEK CO., LTD.(131760)announced on the 24th that it has signed a contract with Samsung Display Vietnam Co. to supply OLED manufacturing equipment worth 19.5 billion won. This amount represents 42.0…
  • 2026-07-24 14:24:58
  • Shin Ha-yeon
Issues & Trends

SAM CHUN DANG PHARM CO. LTD Completes Oral Insulin Treatment for One-Third of All Patients

Samchundang Pharmaceutical ( SAM CHUN DANG PHARM CO. LTD(000250)) announced on the 24th that it has completed dosing for one-third of the total target patient population in the global Phase 1 clinical…
  • 2026-07-24 13:57:16
  • Kwon Oh Seok
Issues & Trends

Align: “GABIA, Inc. Tender Offer Is a Procedural Issue, Not a Price Issue”… Rebuts Macquarie Again

GABIA, Inc.(079940) The battle between Macquarie Asset Management and activist fund Align Partners Asset Management over the tender offer continues. After Macquarie refuted Align’s valuation by emphas…
  • 2026-07-24 13:49:17
  • Kim Kyung-eun
Issues & Trends

NH INVESTMENT & SECURITIES Holds Roundtable with CEOs of Asset Management and Advisory Firms… Strengthens Wealth Management Collaboration

NH INVESTMENT & SECURITIES(005940)announced on the 24th that it hosted a luncheon meeting on the 22nd, inviting chief executive officers (CEOs) from major domestic asset management and investment advi…
  • 2026-07-24 13:27:45
  • Park Sun-Yeop
Disclosure Plus

Celltrion Submits Application for European Marketing Authorization for ‘CT-P55,’ a Biosimilar of Cosentix

(Photo: Celltrion) Celltrion(068270)has applied for European marketing authorization for “CT-P55,” a biosimilar of the autoimmune disease treatment Cosentyx.Celltrion announced on the 24th that it…
  • 2026-07-24 11:50:03
  • KIM SAE-MI
Issues & Trends

Macquarie: “GABIA, Inc.’s Tender Offer Price Reflects a Premium”… Rebuts Major Shareholders

On the 24th, Macquarie Asset Management Group addressed the controversy surrounding the tender offer price for GABIA, Inc.(079940), explaining that “the price reflects a meaningful premium above past …
  • 2026-07-24 11:09:42
  • Kim Kyung-eun
Issues & Trends

The Pinkfong Company, Inc. to Cancel 5 Billion Won in Treasury Stock… 'Two-Track' Approach to Boost Growth and Shareholder Value

#The Pinkfong Company, Inc., famous for intellectual property (IP) such as “Baby Shark,” is accelerating efforts to both return value to shareholders and invest in future growth. The company plans to …
  • 2026-07-24 09:34:18
  • YUN GI BACK
Stocks in Focus

Joins AMD Robotics Partner Network… Nota Inc. Up 6% [Featured Stock]

Shares of #Nota Inc., a company specializing in AI (artificial intelligence) model lightweighting and optimization technologies, are showing strength in early trading. Buying interest appears to be su…
  • 2026-07-24 09:31:33
  • Kwon Oh Seok
KOSDAQ

Evolving K-Content Export Strategy… 'IP Localization' Is the Key to Success

Amid a trend of high exchange rates, the moves of K-content companies are drawing attention. Recently, K-content export strategies have evolved beyond the simple export of intellectual property (IP) t…
  • 2026-07-24 09:28:02
  • Hyera Lee
Stocks in Focus

OCI Holdings Company Ltd. Rises on Expectations of a Return to Profitability in Q2 and Capacity Expansion [Featured Stock]

OCI Holdings Company Ltd. is trading higher after successfully returning to profitability in the second quarter of this year and announcing plans to expand its polysilicon and wafer production capacit…
  • 2026-07-24 09:24:01
  • Park Sun-Yeop
prev 81 82 83 84 85 86 87 88 89 90 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English